News

Enter your email address to get Core One Labs News Alerts.
Company News
March 20, 2021
Core One Labs Files Application to List its Common Shares on NASDAQ
Vancouver, British Columbia, Canada – March 20, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (“Core One” or the “Company”) is pleased to announce that it has filed...
Read more
Company News
March 14, 2021
Core One Labs to Commence Trading in the US on OTC Pink Market
Vancouver, British Columbia, Canada – March 14, 2021 – Core One Labs Inc. (CSE: COOL), (OTC Pink: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) a research and...
Read more
Company News
March 12, 2021
Psychedelic Expert Core One Labs Reports Milestone Acquisition The Developer of Psychedelic Treatments Enters the Telehealth Space with Access to Close to 80,000 Clinic Patients
Vancouver, British Columbia, Canada – March 12, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more
Company News
March 09, 2021
Core One Labs In Collaboration with KICT To Explore DMT Assisted Psychotherapy
Vancouver, British Columbia, Canada – March 9, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
March 04, 2021
Core One Labs’ Subsidiary Vocan to Work with Former Canopy CEO Mr. Marcelo Galvão to License Biosynthesized Psilocybin in Brazil
Vancouver, British Columbia, Canada – March 4, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
February 26, 2021
Core One Labs Initiates First Strain Production for Biosynthetic Psilocybin
Vancouver, British Columbia, Canada – February 26, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) a biotechnology research...
Read more